The global Life Sciences Consulting Services market is valued at over $10 billion in 2021 and is expected to grow at a CAGR of ~10%, driven by increasing R&D in advanced therapies, stringent regulatory compliance, rising need for digitalization/technical expertise, and growing demand for RWE, PV, HEOR, market access services. The life science industry is quickly developing and is witnessing growing complexity, stringent regulations, the need for faster innovation, and the trend towards digitalization. This in turn drives the demand for pharma and biotech consulting services including drug development, regulatory affairs, scientific writing, economic affairs, quality assurance and compliance, real-world evidence (RWE), and pharmacovigilance (PV).